{"id":797632,"date":"2025-01-02T18:43:06","date_gmt":"2025-01-02T23:43:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/"},"modified":"2025-01-02T18:43:06","modified_gmt":"2025-01-02T23:43:06","slug":"neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/","title":{"rendered":"Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – NMRA"},"content":{"rendered":"

<\/p>\n

Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – NMRA<\/b><\/p>\n

LOS ANGELES–(BUSINESS WIRE<\/a>)–The DJS Law Group<\/a> announces that it is investigating claims on behalf of investors of Neumora Therapeutics, Inc. (\u201cNeumora\u201d or \u201cthe Company\u201d) (NASDAQ: NMRA<\/a>) for violations of the securities laws.<\/p>\n

INVESTIGATION DETAILS: <\/b>The investigation focuses on whether the Company issued misleading statements and\/or failed to disclose information pertinent to investors. Bloomberg <\/i>reported on January 2, 2025, that Neumora\u2019s experimental depression treatment had \u201cfailed\u201d the first of three planned studies. Analysts found the Company\u2019s results \u201cvery surprising given the prior data from them and JNJ and reflects a worse-case scenario for the program.\u201d Based on this news, shares of Neumora fell by 81.42% on the same day.<\/p>\n

\nIf you are a shareholder who suffered a loss, contact us to participate<\/a>.<\/p>\n

WHY DJS LAW GROUP?<\/b> DJS Law Group\u2019s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic\/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.<\/p>\n

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250102528797\/en\/<\/a><\/span><\/p>\n

\nDavid J. Schwartz
\n
DJS Law Group
\n
274 White Plains Road, Suite 1
\n
Eastchester, NY 10709
\n
Phone: 914-206-9742
\n
Email: David@djslawllp.com<\/a><\/p>\n

KEYWORDS:<\/b> California United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Class Action Lawsuit Professional Services Legal<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – NMRA LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group announces that it is investigating claims on behalf of investors of Neumora Therapeutics, Inc. (\u201cNeumora\u201d or \u201cthe Company\u201d) (NASDAQ: NMRA) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and\/or failed to disclose information pertinent to investors. Bloomberg reported on January 2, 2025, that Neumora\u2019s experimental depression treatment had \u201cfailed\u201d the first of three planned studies. Analysts found the Company\u2019s results \u201cvery surprising given the prior data from them and JNJ and reflects a worse-case scenario for the program.\u201d Based on this news, shares of … <\/p>\n

Continue reading “Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – NMRA”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-797632","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNeumora Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - NMRA - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - NMRA - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – NMRA LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group announces that it is investigating claims on behalf of investors of Neumora Therapeutics, Inc. (\u201cNeumora\u201d or \u201cthe Company\u201d) (NASDAQ: NMRA) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and\/or failed to disclose information pertinent to investors. Bloomberg reported on January 2, 2025, that Neumora\u2019s experimental depression treatment had \u201cfailed\u201d the first of three planned studies. Analysts found the Company\u2019s results \u201cvery surprising given the prior data from them and JNJ and reflects a worse-case scenario for the program.\u201d Based on this news, shares of … Continue reading "Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – NMRA"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-02T23:43:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250102528797r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – NMRA\",\"datePublished\":\"2025-01-02T23:43:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\\\/\"},\"wordCount\":301,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250102528797r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\\\/\",\"name\":\"Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - NMRA - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250102528797r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-01-02T23:43:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250102528797r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250102528797r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – NMRA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - NMRA - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/","og_locale":"en_US","og_type":"article","og_title":"Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - NMRA - Market Newsdesk","og_description":"Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – NMRA LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group announces that it is investigating claims on behalf of investors of Neumora Therapeutics, Inc. (\u201cNeumora\u201d or \u201cthe Company\u201d) (NASDAQ: NMRA) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and\/or failed to disclose information pertinent to investors. Bloomberg reported on January 2, 2025, that Neumora\u2019s experimental depression treatment had \u201cfailed\u201d the first of three planned studies. Analysts found the Company\u2019s results \u201cvery surprising given the prior data from them and JNJ and reflects a worse-case scenario for the program.\u201d Based on this news, shares of … Continue reading \"Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – NMRA\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-02T23:43:06+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250102528797r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – NMRA","datePublished":"2025-01-02T23:43:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/"},"wordCount":301,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250102528797r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/","name":"Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - NMRA - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250102528797r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-01-02T23:43:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250102528797r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250102528797r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neumora-therapeutics-inc-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-nmra\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – NMRA"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/797632","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=797632"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/797632\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=797632"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=797632"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=797632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}